Last reviewed · How we verify

NCT05787457

Comparative Metabolomics in Diabetes Patients From Sri Lanka and Switzerland

Terminated Last updated 28 March 2023
What this trial tests

trial testing Clinical examination in Diabetes Mellitus, Type 2 in 34 participants. Terminated before completion.

Timeline
31 July 2014
Primary endpoint
30 September 2021
30 September 2021

Quick facts

Lead sponsorInsel Gruppe AG, University Hospital Bern
StatusTerminated
Study typeOBSERVATIONAL
Enrollment34
Start date31 July 2014
Primary completion30 September 2021
Estimated completion30 September 2021
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Insel Gruppe AG, University Hospital Bern

Who can join

Adults 18 to 75, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a case-control study, where the assumed different subtypes of type 2 diabetes in people of Tamil ethnicity and Swiss origin living in Bern, Switzerland will be examined by measuring the metabolite profiles and the corresponding genetic background as well as ethnic differences in fat distribution performed by magnetic resonance imaging (MRI). The investigators aim to show that the specific metabolite profile and the fat distribution in the Tamil population is associated with the high prevalence of diabetes in this ethnicity. Fat distribution patterns are thought to determine the expression and severity of dysglycaemia. Additionally, the investigators aim to identify the key enzymes, their corresponding genes, and the respective polymorphisms relevant for these metabolic variations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Clinical examination

Trials testing the same drug.

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

Other Insel Gruppe AG, University Hospital Bern trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05787457.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing